PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Journal of Affective Disorders0 citationsOpen Access

Lam Employment Absence and Productivity Scale (LEAPS): Analysis of the minimal clinically important difference (MCID) in patients with major depressive disorder using data from the CAN-BIND-1 study

View Full Paper
SSShiny SachdevaVLVictor W. LiTCTrisha Chakrabarty

Key Points

  • The central aim was to determine the minimal clinically important difference (MCID) for the Lam Employment Absence and Productivity Scale (LEAPS) in patients with major depressive disorder.
  • Utilized data from the CAN-BIND-1 study involving patients treated with escitalopram over 8 weeks
  • Employed distribution-based and anchor-based methods to calculate MCID for LEAPS
  • Conducted assessments using LEAPS, Sheehan Disability Scale (SDS), and Quick Inventory of Depressive Symptomatology-Self-Rated (QIDS-SR)
  • The MCID for the LEAPS total score was found to be 3 points and 2 points for the productivity subscale
  • Significant correlation between LEAPS total score and SDS work item (r = 0.598), SDS total score (r = 0.609), and QIDS-SR (r = 0.678)
  • Using the distribution-based method, the MCID for LEAPS total score was calculated as 3.0.

Abstract

Major depressive disorder (MDD) is associated with significant impairment in occupational functioning. The Lam Employment Absence and Productivity Scale (LEAPS) is a self-report questionnaire validated for the assessment of work productivity and absenteeism in patients with MDD. Our study objective was to establish a minimal clinically important difference (MCID) for the LEAPS. Data from the Canadian Biomarker Integration Network in Depression (CAN-BIND)-1 study was used. CAN-BIND-1 involved participants with MDD treated with escitalopram for 8 weeks ( n = 138). Assessments included the LEAPS, Sheehan Disability Scale (SDS), and Quick Inventory of Depressive Symptomatology-Self-Rated (QIDS-SR). The MCID for the LEAPS was calculated using both distribution (value equivalent to half the standard deviation for LEAPS baseline scores) and anchor-based (comparing to the SDS work item) methods. The LEAPS total score was significantly correlated ( p < 0.01) with other measures including SDS work item ( r = 0.598), SDS total score ( r = 0.609), and QIDS-SR ( r = 0.678). Using the distribution-based method, the MCID value for LEAPS total score was 3.0 and MCID for LEAPS productivity subscale score was 1.5. Using the anchor-based method, the MCID value for the LEAPS total score was shown to lie between 2.7 and 3.5 and for the LEAPS productivity subscale score between 0.9 and 1.4. Establishing an MCID is important for determining clinically relevant change in the LEAPS, both for treatment studies and for individual patients in clinical care. For clinical use, the proposed MCID is 3 points for the LEAPS total score and 2 points for the LEAPS productivity subscale score. • Major depressive disorder (MDD) is associated with impairment in work functioning. • The LEAPS is a self-rated scale developed to assess work impairment in patients with MDD. • The minimal clinically important difference (MCID) provides a clinically meaningful change score. • The MCID is 3 points for the LEAPS total score and 2 points for the productivity subscale score. • The LEAPS MCID can assess improvement in work functioning for clinical trials and clinical care.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sachdeva et al. (2026) studied this question.

synapsesocial.com/papers/69994a7f873532290d01ef01https://doi.org/10.1016/j.jad.2026.121451
Ask AI
Helpful
Bookmark
Share
View Full Paper